Breast Cancer Misdiagnosis Claims in Ireland: Compensation, Evidence, and Your Legal Options
Breast cancer misdiagnosis claims arise when a GP, radiologist, or hospital fails to diagnose breast cancer on time, and that delay causes you measurable harm. According to the NCRI Annual Statistical Report (December 2024), breast cancer accounts for almost one third of all invasive cancers in Irish women, with over 3,600 new female cases per year. Roughly 25 to 40 men are also diagnosed annually. When breast cancer is caught at Stage I, the five-year survival rate sits at approximately 99%. That figure drops to as low as 29% at Stage IV. The distance between those two numbers is the foundation of every delayed diagnosis claim we handle.
Contents
What counts as breast cancer misdiagnosis under Irish law?
Breast cancer misdiagnosis occurs when a clinician fails to identify, correctly interpret, or act on signs of breast cancer within a reasonable timeframe. Under the legal test established in Dunne v National Maternity Hospital [1989] IR 91, the failure must fall below the standard expected of a competent professional of equal specialist status. Unlike in England and Wales, where the Bolam test historically allowed doctors wider latitude, Irish courts apply the Dunne principles with an additional safeguard: a practice can still be negligent even where other doctors followed the same approach, provided the practice contains inherent defects that should be obvious on careful consideration.
Misdiagnosis takes several forms in breast cancer cases. A GP may dismiss a palpable lump as hormonal. A radiologist may misread a mammogram. A pathologist may return a false-negative biopsy result. What connects them is the breach: had the clinician followed the expected protocol, the cancer would have been detected earlier and treated less aggressively.
One detail that catches many claimants off guard: a breast cancer claim does not require proof that the cancer would have been cured. Irish law recognises the loss of opportunity to receive earlier, less invasive treatment as a compensable injury in its own right, following the Supreme Court's decision in Philp v Ryan [2004] IESC 105. We call this the stage-shift gap, and it is the central calculation in virtually every breast cancer negligence case we assess.
The triple assessment: Ireland's legal standard of care for breast cancer
The triple assessment is a three-part diagnostic protocol that every symptomatic breast patient should receive under NCCP guidelines. According to the NCCP National Clinical Guidelines for the Diagnosis and Staging of Patients with Breast Cancer (radiology section updated ) 2, the protocol consists of three mandatory components:
- Clinical examination of the breast tissue and axillary lymph nodes by a qualified clinician.
- Radiological imaging, typically mammography for women over 40 and ultrasound for younger patients with denser breast tissue.
- Histopathological assessment, usually an ultrasound-guided core needle biopsy reviewed by a pathologist to confirm or exclude malignancy.
Skipping any component, or failing to escalate when findings are inconclusive, breaches the expected standard of care. The NCCP guidelines also stipulate that where malignancy is confirmed, surgical treatment should commence within 14 days to prevent disease progression. A detail the official guidance does not cover: in practice, incomplete triple assessments are the single most common breach pattern in the breast cancer cases referred to our office. A patient presents with a lump, receives a mammogram that appears clear, and is discharged without the biopsy that would have caught the cancer.
BI-RADS scoring: how radiologists classify mammogram findings
Radiologists grade every mammogram using the BI-RADS (Breast Imaging Reporting and Data System) classification, scoring findings from 0 (incomplete, further imaging needed) through to 5 (highly suggestive of malignancy). The core breach pattern in mammographic misdiagnosis is a radiologist assigning BI-RADS 1 (negative) or BI-RADS 2 (benign) to an image that, on retrospective expert review, should have been scored BI-RADS 4 (suspicious) or BI-RADS 5 (highly suggestive). Your independent radiologist will compare the original score against what the imaging actually showed, and that comparison forms the documentary foundation of the breach argument. Obtaining your BI-RADS classification from the original mammogram report is one of the first steps in any screening-related claim.
Where do breast cancer misdiagnoses happen in Ireland?
Breast cancer misdiagnoses originate across primary care, screening programmes, and hospital settings, each involving a different breach pattern. According to the NCCP's clinical guidelines and HSE referral data, the most common failure points fall into six categories.
| Setting | Clinical error | Standard breached |
|---|---|---|
| GP surgery | Dismissing a palpable lump as a benign cyst or hormonal change without referral | NCCP referral guidelines mandate urgent electronic referral via Healthlink to a Symptomatic Breast Disease (SBD) clinic |
| SBD clinic / hospital | Incomplete triple assessment: imaging performed but biopsy omitted | NCCP triple assessment protocol. HSE KPI: 95% of urgent patients seen within 10 working days at one of the eight designated centres (Beaumont, Mater, St. Vincent's, St. James's, Cork University, Galway University, UH Limerick, UH Waterford) or the Letterkenny satellite |
| Radiology | Misreading mammogram: missed micro-calcifications or architectural distortions | Dunne standard: no competent radiologist exercising ordinary care would have cleared the image |
| Pathology | False-negative core biopsy (estimated 5 to 10% false-negative rate in published literature) | Failure to recommend repeat biopsy or surgical excision when clinical suspicion persists |
| BreastCheck screening | Mammogram read as normal when suspicious features were present on retrospective review | HSE non-delegable duty of care in population screening, confirmed in Morrissey v HSE [2020] IESC 6 |
| GP (under-40s / post-partum) | Attributing breast changes to pregnancy, breastfeeding, or age without investigation. Pregnancy-associated breast cancer (PABC) carries diagnostic delays averaging 2 to 6 months because symptoms mimic normal hormonal changes | NCCP guidelines apply regardless of patient age or pregnancy status. Symptoms warrant referral |
Recent Oireachtas data reveals the scale of access delays. According to a parliamentary answer (), national compliance with the HSE's 10-working-day urgent referral target stood at only 76% between March 2024 and February 2025. Compliance varied sharply by hospital: the Mater Hospital reached just 29%, and St. James's Hospital 51%. Systemic delays of this kind can convert a curable Stage I diagnosis into a Stage III or IV scenario.
High-risk profiles: dense breast tissue and BRCA mutations
Standard mammography has reduced sensitivity in women with extremely dense breast tissue, detecting as few as 48% of cancers in the densest category. The NCCP guidelines require ultrasound as an adjunct to mammography in these patients. A radiologist or GP who relies solely on a mammogram in a patient with known dense breasts, and returns a clear result without recommending ultrasound, breaches the expected standard. This failure pattern appears frequently in cases involving women under 40.
Patients carrying BRCA1 or BRCA2 gene mutations face a substantially higher lifetime risk of breast cancer and require annual MRI surveillance beginning at an earlier age. A failure to refer patients with a known family history of breast or ovarian cancer for genetic counselling and enhanced screening constitutes a distinct breach of duty. The causation argument in BRCA cases is often stronger than in standard screening cases because the heightened baseline risk makes early detection even more critical.
Can you claim if BreastCheck missed your cancer?
You can bring a claim against the HSE where BreastCheck screening mammograms were negligently misinterpreted, but you must prove the cancer was visible on the original images. BreastCheck provides free mammograms every two years to women aged 50 to 69, processing over 150,000 invitations annually with an uptake rate exceeding 72%. The programme is currently expanding eligibility to age 74, meaning women in the 70 to 74 range who have not yet been invited may have delayed diagnoses attributable to the phased rollout. Screening errors typically involve micro-calcifications or architectural distortions that a competent radiologist should have identified.
The Supreme Court confirmed the HSE's non-delegable duty of care for population screening programmes in Morrissey v HSE [2020] IESC 6. While that case concerned CervicalCheck, the principle applies directly to BreastCheck: the HSE cannot avoid liability by delegating screening to third-party radiologists. The to Barringtons Hospital symptomatic breast care failures in the Mid-West region remain cited in current case law as evidence of systemic patterns in breast screening negligence.
The Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023 (Act No. 10) introduces provisions under Part 5 allowing patients to request a formal review of their screening results after a subsequent cancer diagnosis. Obtaining your BreastCheck records, including the original mammographic images, is a critical first step. Your solicitor can request these through the HSE's data access process.
Not every cancer found after a clear screening is evidence of negligence. Cancers that develop between screening appointments are known as interval cancers, and this distinction is central to every BreastCheck claim. We address the defences hospitals raise in the next section.
How delay changes prognosis: survival by stage
The stage at which breast cancer is diagnosed determines both survival probability and treatment intensity, and the difference between stages is the core of the compensation argument. According to published five-year net survival data from the NCRI and international registries, each stage represents a measurably worse outcome. Each row in the table below represents a stage-shift gap: the distance between what your outcome should have been and what it became because of the delay.
| Stage | Five-year survival | Typical treatment | Legal significance |
|---|---|---|---|
| I | 98 to 99% | Lumpectomy, possible radiotherapy | Benchmark: the outcome if diagnosed on time |
| II | 89 to 92% | Surgery, chemotherapy, radiotherapy | More aggressive treatment than Stage I |
| III | 71 to 75% | Mastectomy, systemic chemotherapy, targeted therapies | Significant stage-shift gap |
| IV | 29 to 37% | Palliative and systemic treatment | Maximum stage-shift gap. Largest compensation claims |
The timing matters more than you might expect: a 12-month delay may shift a patient from Stage I to Stage III, transforming a lumpectomy into a radical mastectomy followed by months of chemotherapy. The stage-shift gap captures both the physical harm (more invasive treatment, reduced survival) and the psychological injury (knowing the cancer could have been caught earlier). This dual calculation drives every quantum assessment in breast cancer negligence.
How is breast cancer negligence proved in Irish courts?
Proving breast cancer negligence requires three elements: breach of duty, causation, and quantifiable harm. The legal test is Dunne v National Maternity Hospital [1989] IR 91: the claimant must show that no competent professional of equal specialist status, exercising ordinary care, would have made the same error.
Expert evidence you will need
Each element of the triple assessment requires a different expert. A consultant radiologist reviews the original mammographic images. A histopathologist re-examines biopsy slides. A breast surgeon assesses whether the clinical examination met the expected standard. An oncologist then links the delay to a specific stage-shift and calculates the impact on prognosis, treatment, and life expectancy. A consultant psychiatrist quantifies the psychological injury, including anxiety disorder, depression, and PTSD arising from the avoidable delay. An actuarial expert calculates past and future loss of earnings where the diagnosis has reduced working capacity. For detailed guidance on engaging experts, see our expert medical report guide.
Causation: the stage-shift gap in practice
The causation hurdle in breast cancer cases is uniquely demanding. You must establish what stage the cancer was at when it should have been diagnosed, what stage it was at when it was actually diagnosed, and what difference the delay made to treatment and outcome.
Irish law provides a significant advantage here. Unlike in England and Wales, where the House of Lords decision in Gregg v Scott [2005] generally prevents recovery where initial survival chances fell below 50%, the Irish Supreme Court in Philp v Ryan [2004] IESC 105 recognised that the loss of a chance of a better outcome is a compensable injury in its own right. The High Court awarded the plaintiff €45,000. The Supreme Court increased the award to €100,000. This means an Irish claimant can recover damages for lost life expectancy and the deprivation of informed treatment choices, even where survival odds were already reduced.
| Element | Ireland | England and Wales |
|---|---|---|
| Leading case | Philp v Ryan [2004] IESC 105 | Gregg v Scott [2005] UKHL 2 |
| Loss of chance | Compensable as a standalone injury | Generally not recoverable where survival chance was below 50% |
| What claimant must prove | Delay deprived patient of opportunity for earlier, less invasive treatment or longer life expectancy | On the balance of probabilities, the outcome would have been different |
| Practical effect | Claims can succeed even in advanced cancer cases | Claims often fail where cancer was already aggressive at the time of the missed diagnosis |
Your oncology expert quantifies the stage-shift gap using clinical prognostic tools, such as the Nottingham Prognostic Index, which calculates expected outcomes based on tumour size, lymph node status, and histological grade at each stage.
For a full explanation of how causation works in Irish medical negligence, see our causation guide.
What defences will the hospital raise against a breast cancer claim?
The State Claims Agency and hospital defence teams deploy two primary strategies in breast cancer cases, both designed to break the causation chain. Understanding these defences before you begin is essential to building a case that survives scrutiny.
The interval cancer defence
Defence teams argue that the cancer was a "true interval cancer" that developed rapidly between screening appointments and was not radiologically visible on the earlier mammogram. Because BreastCheck screens biennially, this argument surfaces in almost every screening case. A subsequent diagnosis does not automatically prove the earlier screen was negligent. To defeat this defence, your independent radiologist must demonstrate that suspicious features, such as micro-calcifications or architectural distortions, were present on the original images and were negligently categorised as normal.
The tumour doubling-time defence
Defence experts sometimes argue that the tumour was either so biologically aggressive that earlier detection would not have changed the outcome, or so slow-growing that the delay caused no material difference to treatment. We call this the stage-shift gap paradox: defendants try to collapse the gap from both sides simultaneously. The Irish High Court has rejected arguments relying solely on generalised mathematical models of tumour growth rates, finding them unreliable for individual clinical cases. Your oncology expert must instead triangulate actual clinical staging records, imaging timelines, and histological reports to demonstrate that timely detection would have led to a materially better outcome on the balance of probabilities.
Does a hospital apology prove negligence?
A hospital apology, including one made during open disclosure, is not admissible as evidence of fault or liability in court. Under s.10 of the Civil Liability (Amendment) Act 2017, information provided during open disclosure and any apology given cannot constitute an admission of liability and cannot be used in litigation. Many patients assume "they said sorry, so they've admitted fault," but that is not how Irish law treats open disclosure statements. Your claim still requires independent expert evidence proving breach, causation, and harm, regardless of what the hospital told you.
For a broader overview of how defendants respond to medical negligence claims, see our common defences guide.
Defence strategy decoder: select a defence to see how it works and how to counter it
What they argue: The cancer was a "true interval cancer" that developed rapidly between biennial BreastCheck appointments and was not visible on the earlier mammogram.
Why it can fail: Independent expert review of the original mammogram may reveal suspicious features (micro-calcifications, architectural distortions) that were negligently reported as normal.
Evidence that defeats it: Side-by-side comparison of original and retrospective BI-RADS scoring by an independent consultant radiologist.
When does the two-year clock start for breast cancer claims?
Under the Statute of Limitations 1957, the two-year limitation period for a breast cancer misdiagnosis claim in Ireland begins on your "date of knowledge", not the date the original clinical error occurred. In breast cancer cases, the date of knowledge is the date you first became aware, or should reasonably have become aware, that your delayed diagnosis resulted from substandard medical care.
Consider two common scenarios. You have a clear mammogram in 2022. In 2024, you're diagnosed with Stage III breast cancer. Your oncologist tells you the cancer was likely present at the time of the original screening. That conversation, or a similar communication from a second clinician, typically triggers the date of knowledge. Alternatively, you experience a recurrence that prompts a retrospective review of earlier imaging, revealing a missed lesion. The date of that review, not the original mammogram, starts the clock.
Contact a solicitor urgently, if your diagnosis happened more than 18 months ago and you have not yet taken legal advice. The two-year window closes without warning.
One connection that surprises many claimants: under the Patient Safety Act 2023, the HSE is required to disclose notifiable patient safety incidents to affected patients through open disclosure. The hospital's open disclosure conversation, where you are told the screening error occurred, may itself establish your date of knowledge for limitation purposes. Record the date, who spoke to you, and what was said. That record can determine whether your claim is in time.
The distinction between the date of the error and the date of knowledge catches many people. For the detailed statutory rules, exceptions for children, and capacity provisions, see our date of knowledge guide.
Concerned about a delayed breast cancer diagnosis? Contact Gary Matthews Solicitors for a no-obligation assessment of your case. Call 01 903 6408 or request a callback. We handle breast cancer negligence claims on a no-win, no-fee basis.
*In contentious business, a solicitor may not calculate fees or other charges as a percentage or proportion of any award or settlement. This statement is made in compliance with Reg. 8 of S.I. No. 644 of 2020.
What compensation applies to breast cancer misdiagnosis cases in Ireland?
Compensation in breast cancer claims divides into general damages (pain, suffering, and loss of amenity) and special damages (quantifiable financial losses), and in cancer cases the special damages frequently exceed the general damages figure. According to the Judicial Council's Personal Injuries Guidelines (2021), indicative ranges are provided by severity, but breast cancer cases are assessed on facts specific to your stage-shift, treatment pathway, and long-term prognosis.
General damages: what courts assess
Courts consider the physical trauma of undergoing more invasive treatment than would have been necessary with earlier detection. A radical mastectomy with reconstruction, systemic chemotherapy, and prolonged radiotherapy produces a different general damages assessment than a lumpectomy with short-course radiotherapy. Later-stage diagnoses also frequently require full axillary lymph node clearance, which can cause lymphoedema, a permanent swelling condition requiring lifelong management. Lymphoedema is avoidable in early-stage cancers where only a sentinel node biopsy is needed, making it a direct and quantifiable consequence of the stage-shift gap. The psychological injury of learning about an avoidable delay, including anxiety about recurrence and reduced life expectancy, forms a significant component.
Special damages specific to breast cancer
Special damages in breast cancer cases frequently include the cost of breast reconstruction (where not provided by the HSE), targeted pharmacological therapies (such as trastuzumab for HER2-positive cancers), ongoing counselling and psychological support, and past and future loss of earnings calculated with actuarial evidence. For younger women of reproductive age, aggressive chemotherapy can damage fertility permanently, and the cost of pre-treatment egg freezing, embryo storage, and subsequent IVF treatment forms a distinct head of special damages that applies only to this cohort. One aspect the official guidance does not cover: where treatment forces early retirement or significantly reduces working capacity, the loss-of-earnings claim can exceed all other heads of damage combined.
A compounding factor in delayed diagnosis cases: the delay in diagnosis itself may be followed by further delays in commencing post-surgical chemotherapy, reducing treatment effectiveness. Your legal team can claim for both the diagnostic delay and any consequential treatment delay as linked elements of the same breach.
For a full breakdown of how general and special damages work, see our what you can claim for guide and our compensation hub.
What if you delayed going to the GP yourself?
Courts can reduce compensation where the claimant contributed to their own harm. Under the Civil Liability Act 1961, contributory negligence applies where you delayed seeking medical attention after noticing symptoms, or failed to attend scheduled BreastCheck appointments. The reduction is proportionate: a court assessing that the patient's own delay accounted for 20% of the overall harm would reduce the award by that percentage. Your solicitor will assess this risk early and factor it into the case strategy.
Irish case outcomes and settlements in breast cancer claims
Irish courts have overseen multiple high-value settlements in breast cancer misdiagnosis cases, driven by the severity of the delay and the resulting impact on treatment and survival. The following anonymised examples provide context, not guarantees, for what Irish courts have awarded.
| Hospital / setting | Reported settlement | Key facts |
|---|---|---|
| St. Vincent's University Hospital | €1,000,000 | Cancer undiagnosed for over two years despite symptoms at a designated centre of excellence. Cancer metastasised to brain and liver. |
| Cork University Hospital | €630,000 | Delayed diagnosis in a woman in her 40s. Failure to follow national diagnostic standards led to overtreatment. |
| Galway University Hospital | Undisclosed (substantial) | 11-year failure to diagnose. Expert evidence suggested the tumour was visible on mammograms from 1996. Settlement included HSE-funded breast reconstruction. |
| Fatal claim (dependants) | €325,000 | Approved for a 13-year-old boy following the death of his mother due to delays in diagnosing evolving breast cancer. |
Every case depends on its own facts. Past settlements do not predict future outcomes. All figures are drawn from publicly reported sources.
Male breast cancer: a higher misdiagnosis risk
Male breast cancer accounts for approximately 25 to 40 cases annually in Ireland, according to NCRI data, and carries a disproportionately high misdiagnosis risk because clinical suspicion is low. Symptoms in men, including a painless mass behind the nipple or axillary lymph node enlargement, are frequently attributed to benign conditions such as gynecomastia or superficial infections (HSE, 2025).
The same triple assessment standard applies to men as to women. A GP who dismisses a breast lump in a male patient without referral for imaging and biopsy breaches the NCCP guidelines. Because of the lack of suspicion, male breast cancers are often diagnosed at a later stage, requiring more aggressive treatment and resulting in poorer outcomes. The legal framework for claiming is identical: breach of the triple assessment standard, causation through stage-shift, and compensation calculated on the same principles.
How does a breast cancer negligence claim work in practice?
Clinical negligence claims in Ireland bypass the Injuries Resolution Board entirely and proceed directly through the court system, governed since by Practice Directions HC131 and HC132. These rules created a dedicated Clinical Negligence List with active case management by specialised judges.
The practical steps follow a sequence. Your solicitor obtains your full medical records, including original imaging. Independent experts review the records across each component of the triple assessment. A letter of claim is issued. Pre-proceedings mediation is offered. The case enters the Clinical Negligence List. HC131/HC132 require parties to formally offer mediation within three weeks of fixing a trial date.
The defendant you name depends on where the error occurred. Claims arising in public hospitals are brought against the HSE, defended by the State Claims Agency. Claims arising in private hospitals or clinics are brought against the consultant personally, the private hospital, or both, defended by their medical indemnity insurers. The distinction affects the litigation timeline: SCA-defended cases follow a more structured process, while private defendant cases can move faster but may involve more contested liability.
According to the State Claims Agency's 2024 mediation data, 43% of concluded clinical claims were resolved through mediation, meaning the majority of claimants avoid a public trial. Between assessment and settlement, the sticking point is usually the oncology experts' competing views on the stage-shift gap. For a full overview of the claims process, including timelines and what to expect at each stage, see our process hub.
| Phase | Typical duration | What happens |
|---|---|---|
| Medical records request | 6 to 12 weeks | Full records obtained from hospital, GP, and BreastCheck (if applicable) |
| Independent expert review | 3 to 6 months | Radiologist, pathologist, breast surgeon, and oncologist each review records and provide reports |
| Letter of claim and pre-action | 2 to 4 months | Formal letter issued. HSE/SCA or private defendant responds |
| Proceedings and case management | 12 to 24 months | Case enters HC131/HC132 Clinical Negligence List. Discovery, exchange of expert reports |
| Mediation or trial | 1 to 3 months | Mediation offered within 3 weeks of trial date. 43% of clinical claims resolve at mediation |
Timelines vary by case complexity. Fatal claims and cases involving multiple defendants may take longer. Your solicitor will give you a realistic estimate based on your specific facts.
What to consider next
If you suspect a missed or delayed breast cancer diagnosis:
Request your medical records. Ask your hospital and GP for the complete file, including all imaging studies and pathology reports. Our medical records request guide explains the process step by step.
Check your dates. Work out when you first became aware that the delay may have been caused by substandard care. That is your date of knowledge, and your two-year clock runs from that point. Our date of knowledge page covers the detailed rules.
Get a no-obligation case assessment. A solicitor experienced in breast cancer negligence can tell you quickly whether the facts support a claim. Call 01 903 6408.
Before your first consultation, gather: your GP referral letter, all imaging dates and reports (including your BI-RADS classification), pathology results, your treatment timeline from diagnosis to present, any hospital correspondence including open disclosure letters, and receipts for medical or travel expenses. Arriving with these documents allows your solicitor to assess your case in a single meeting rather than waiting weeks for records.
If the patient has died. Dependants can bring a fatal injury claim. Our claims after death guide covers the rules for estate and dependency claims.
Could you have a breast cancer misdiagnosis claim?
Answer four questions to check whether your situation may warrant a legal assessment. This tool does not provide legal advice.
Were you diagnosed with breast cancer after a prior screening, GP visit, or hospital assessment that gave you the all-clear?
This tool provides general guidance only. It is not legal advice and does not create a solicitor-client relationship. Every case depends on its own facts.
Common questions about breast cancer misdiagnosis claims
What is the triple assessment and why does it matter legally?
The triple assessment is a three-stage diagnostic protocol (clinical exam, imaging, biopsy) mandated by the NCCP for all symptomatic breast presentations. Failure to complete all three stages is the most common breach pattern in Irish breast cancer claims.
In practice: Incomplete assessments, particularly imaging without biopsy, account for the majority of referrals we receive.
Read more: Cancer misdiagnosis claims hub
How much compensation for breast cancer misdiagnosis in Ireland?
Awards depend on the stage-shift gap: how far the cancer advanced due to the delay, and how that affected treatment intensity, survival, and quality of life. Publicly reported Irish settlements range from €325,000 to €1,000,000.
Important: Past settlements are not guarantees. Every case is assessed on its own facts and medical evidence.
Full guide: Compensation hub
Can I claim if BreastCheck missed my breast cancer?
You can claim where an independent radiologist confirms that suspicious features were visible on the original mammogram and were negligently reported as normal. The HSE holds a non-delegable duty of care for population screening programmes.
Key distinction: A subsequent cancer diagnosis does not automatically mean the screening was negligent. The cancer may be a true interval cancer.
Related: Misdiagnosis claims hub
What is the time limit for a breast cancer negligence claim?
Two years from the date of knowledge: the date you became aware, or should reasonably have become aware, that the delayed diagnosis resulted from substandard medical care.
Common scenario: A recurrence or second opinion may trigger the date of knowledge years after the original screening error.
Detailed guide: Date of knowledge guide
Can I claim if my survival chances were already below 50%?
Yes, under Irish law. The Supreme Court in Philp v Ryan [2004] IESC 105 recognised the loss of a chance of a better outcome as a compensable injury. This differs from the position in England and Wales.
Why it matters: This doctrine allows claims even in advanced cancer cases where the delay reduced already-compromised survival odds.
See also: Causation in medical negligence
Does a breast cancer claim go through the Injuries Resolution Board?
No. Clinical negligence claims are exempt from the IRB under s.3(d) of the PIAB Act 2003 and proceed directly through the High Court. Since April 2025, these cases are managed under Practice Directions HC131 and HC132.
Learn more: Settlement vs trial guide
Is no-win, no-fee available for breast cancer claims?
Yes. Most specialist medical negligence solicitors in Ireland, including our firm, handle breast cancer claims on a no-win, no-fee basis. You pay no solicitor fees unless compensation is recovered.
Transparency note: Under S.I. No. 644 of 2020, solicitors cannot calculate fees as a percentage of any award.
Details: No-win, no-fee explained
Can men claim for breast cancer misdiagnosis?
Yes. Male breast cancer accounts for 25 to 40 cases annually in Ireland. The same triple assessment standard applies, and the higher misdiagnosis rate in men often results in later-stage diagnosis and stronger causation arguments.
Related guide: Cancer misdiagnosis hub
Will my breast cancer case go to a public trial?
Most do not. According to the State Claims Agency's 2024 data, 43% of concluded clinical claims were resolved through mediation. The HC131/HC132 rules require formal mediation offers before trial, making non-court resolution increasingly common.
Full guide: Settlement vs trial guide
What if the patient has died from breast cancer negligence?
Dependants can bring a claim under the Civil Liability Act 1961 for both dependency losses and solatium (capped at €35,000 total, shared among all dependants). The estate can also claim for the deceased's pain and suffering before death.
Further reading: Claims after death guide
Will making a claim affect my ongoing cancer treatment?
No. Your legal claim is entirely separate from your clinical care. The HSE does not alter treatment because of pending litigation, and your medical team will not be involved in the legal process. Independent experts retained by your solicitor review your records separately. Your treating doctors continue your care as normal.
Common concern: Many patients worry about this before contacting a solicitor. The separation between clinical care and legal proceedings is absolute.
References
All links verified 30 March 2026.
[1] NCRI, Cancer in Ireland 1994 to 2022: Annual Statistical Report (December 2024)
[3] Statute of Limitations 1957, s.11
[4] Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023 (Act No. 10)
[5] Oireachtas Parliamentary Question, Cancer Services (June 2025)
[6] State Claims Agency, Mediation and Alternative Dispute Resolution (2024 data)
[8] HSE, Breast Cancer in Men: Diagnosis (2025)
[9] Breast Cancer Ireland, Facts and Figures (2025)
[10] Civil Liability (Amendment) Act 2017, s.10 (open disclosure and apology)
Disclaimer: This article provides general information about breast cancer misdiagnosis claims in Ireland. It is not legal advice and should not be relied upon as a substitute for professional legal consultation tailored to your individual circumstances. Each case depends on its own facts. No solicitor-client relationship is created by reading this content.
Gary Matthews Solicitors
Medical negligence solicitors, Dublin
We help people every day of the week (weekends and bank holidays included) that have either been injured or harmed as a result of an accident or have suffered from negligence or malpractice.
Contact us at our Dublin office to get started with your claim today
